FIELD: medicine.
SUBSTANCE: invention relates to medicine, namely to neurology, psychiatry and pediatrics. Factors of perinatal pathology risk are determined: extragenital diseases of mother during pregnancy and labour, complications of pregnancy and labour, low gestational age, estimation by Apgar scale and compromised obstetric history. Also determined is presence of neurological malfunctions during 1-st year of life: syndromes of motor malfunctions, increased neuroreflex excitability, vegetative-visceral disorders, depression, retardation of physhomotor and speech development; and in older age - cerebrosthenic syndrome and syndrome of child dysphasia in structure of symptom complex of MBD, epileptiform activity by EEG. Results of questionnaire for MBD detection are evaluated in points. Prognostic coefficients F1 and F2 are calculated in discriminating equations. If F1 is higher than F2, favorable course of MBD is predicted, if F1 is less than F2, unfavorable course of MBD is predicted.
EFFECT: method makes it possible to increase reliability of MBD course prediction.
2 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF ASSESSING THE REHABILITATION POTENTIAL OF A PATIENT WHO UNDERWENT CORONARY ARTERY STENTING IN THE ACUTE PERIOD OF MYOCARDIAL INFARCTION | 2022 |
|
RU2803005C1 |
METHOD OF PREDICTING DEVELOPMENT OF BRAIN DYSFUNCTION IN CHILDREN WHO DO NOT HAVE CLINICAL SIGNS OF DISEASE | 2012 |
|
RU2481792C1 |
METHOD FOR PREDICTION OF ATOPIC DERMATITIS FORMATION IN CHILDREN | 2014 |
|
RU2568738C1 |
METHOD OF PREDICTING BODY WEIGHT OF NEWBORN BABY | 2011 |
|
RU2472446C1 |
METHOD FOR PREDICTING CLINICAL EFFECTIVENESS OF CLIMACTERIC SYNDROME MELATONIN IN FEMALES IN PERIMENOPAUSAL AND POSTMENOPAUSAL WOMEN | 2019 |
|
RU2723764C1 |
POLYPEPTIDE DEMONSTRATING ANTIBACTERIAL ACTIVITY AND SUITABLE FOR OBTAINING THERAPEUTIC MEDICATIONS FOR TREATMENT OF HUMAN BACTERIAL INFECTIONS | 2010 |
|
RU2434880C1 |
METHOD FOR PREDICTING THE ONSET OF ICP IN CHILDREN OF THE FIRST 3 MONTHS OF LIFE WITH CNS PERINATAL AFFECTION | 2018 |
|
RU2710218C1 |
GENE-THERAPEUTIC METHODS FOR ADMINISTRATION OF APOLIPOPROTEIN A-1 AGONISTS AND THEIR USING IN TREATMENT OF DYSLIPIDEMIC DISORDERS | 1998 |
|
RU2222545C2 |
METHOD OF PREDICTING FORMATION OF POST-OPERATION ABDOMINAL HERNIAS | 2008 |
|
RU2370216C1 |
METHOD FOR PREDICTING MYOCARDIAL INFARCTION OUTCOME | 2004 |
|
RU2276573C2 |
Authors
Dates
2013-08-20—Published
2012-03-30—Filed